Morgan Stanley analyst Matthew Harrison said in a research note Tuesday that 26% of biotechnology companies need funding.The firm estimates ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE